In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ethicon Inc.

Division of Johnson & Johnson
www.ethiconinc.com

Latest From Ethicon Inc.

Ethicon Acquires TachoSil Surgical Patch From Takeda For $400M

Ethicon will acquire the assets and licenses of TachoSil for $400m and add about 80 Takeda employees, while Takeda will maintain ownership of the TachoSil manufacturing facility in Linz, Austria.

M & A Commercial

Takeda Offloads Xiidra As Expected, For $3.4bn Upfront To Novartis

As widely anticipated, Takeda has reached an agreement to divest an ex-Shire ophthalmology drug, as it streamlines the combined post-acquisition business to focus on core therapeutic pillars.

Ophthalmic Deals

J&J Cleared In Philly Pelvic Mesh Trial

Product liability cases alleging manufacturers of pelvic mesh are responsible for patient injuries continued even as the US FDA is halting sales of the product. In the most recent verdict, a Philadelphia jury said Johnson & Johnson was not responsible for adverse events experienced by a Pennsylvania woman.

Legal Issues Safety

Pennsylvania Jury Slams Ethicon With $41M Verdict In Mesh Case

Johnson & Johnson subsidiary Ethicon has been ordered to pay $41m to a plaintiff who says she was injured by the company’s pelvic mesh products.

See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register